Protect Yourself From Exposed Sharps With MedPro Safety Products

Posted by Laura Swartz

May 22, 2012 at 3:24 PM

Our latest Quarterly Update is on an innovative company developing safer products for medicine delivery and blood collection. MedPro Safety Products, Inc. (MPSP-OTC) possesses a medical device technology designed to prevent needlestick injuries, since skin punctures by a hypodermic needle, syringe, or other sharp can expose people to bloodborne pathogens.

Read More

Topics: MedPro, Prefilled Syringe

"Beyond Wall Street's Panama Canal" Makes Case for Independent Research

Posted by Laura Swartz

May 21, 2012 at 11:32 AM

Crystal Research Associates' Director of Healthcare, David H. Talbot, discusses research trends in small-cap stocks on Seeking Alpha. Article excerpt below; click here for a link to the full text.

Read More

Topics: Crystal Research Associates, New Research

LRAD Corp.'s Acoustic Technology To Be Used at 2012 NATO Summit

Posted by Colleen Koski

May 16, 2012 at 3:39 PM

The Chicago Police Department has announced that it will use LRAD Corp.'s (LRAD-NASDAQ) long-range acoustic devices (LRAD) to communicate to crowds during the 2012 NATO Summit in Chicago. This is one of many safety and security measures the city has put in place in preparation for the event, which begins Sunday, May 20, 2012. Various protests and demonstrations are expected leading up to and throughout the Summit. 

Read More

Topics: LRAD

BELLUS Health Reports 1Q Financial Results, Provides Corporate Update

Posted by Colleen Koski

May 15, 2012 at 6:05 PM

May 15, 2012 (CNW), LAVAL, QC-- 

Read More

Topics: Bellus Health, KIACTA, Pharmascience, VIVIMIND

LRAD Corp. Receives $1.7 Million LRAD-RX Order for Asian Maritime Security

Posted by Colleen Koski

May 15, 2012 at 5:05 PM

May 15, 2012 (Marketwire), SAN DIEGO, CA-- 

Read More

Topics: LRAD

Sustainable Technologies Gain Momentum: New Report Highlights News

Posted by Laura Swartz

May 15, 2012 at 8:53 AM

As researchers have recently emphasized, governments have a significant role and responsibility for providing long-term support for renewable energy, smart grid, and other future “sustainable city” initiatives. The price of renewable energies and associated technologies are too high to appeal to investors without government support. Mechanisms such as incentives, feed‐in‐tariffs, tax‐breaks, rebates, and other financial instruments are critical.

With that in mind, we have released a 12-page report that expands upon several U.S. policies expected to further market adoption of sustainable, nanotechnology-driven technologies. The report, Continuing Coverage of Nanotechnology and the Built Environment (available here), is the latest update to our base report, Nanotechnology and the Built Environment: The Transition to Green Infrastructure. This update is part of a series of “continuing coverage” reports from Crystal Research Associates that detail innovations in nanotechnology and their impact on our infrastructure, building, and construction markets.

Read More

Topics: nanotechnology, built environment, green infrastructure, Crystal Research Associates

Crystal Research CEO Jeffrey Kraws Appointed Chairman of the Board, Synthetic Biologics (SYN-NYSE Amex)

Posted by Colleen Koski

May 11, 2012 at 12:25 PM

ANN ARBOR, Mich.May 11, 2012  /PRNewswire/ -- 

Synthetic Biologics, Inc. (SYN-NYSE Amex), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today that to improve its corporate governance and strengthen the Board, it has split the roles of Chairman and Chief Executive Officer, and appointed Jeffrey J. Kraws to serve as its independent, non-executive Chairman of the Board. Mr. Kraws has served on the Company's Board of Directors since January 2006, and will continue to serve on the Compensation and Nominations Committees.

Read More

Topics: Crystal Research Associates, Synthetic Biologics

MedPro and Unilife Featured in Drug Development & Delivery Magazine

Posted by Colleen Koski

May 11, 2012 at 9:20 AM

MedPro Safety Products, Inc. (MPSP-OTC.BB) and Unilife Corporation (UNIS-NASDAQ) were featured in the May 2012 edition of Drug Development & Delivery in an article, entitled "Prefilled Syringes - A Container of Choice for Pharma." Drug Development & Delivery interviewed leading players in the prefilled syringe market to learn about their products and how each company is addressing pharma’s needs for safety, ease of use, cost, and product differentiation. 

Read More

Topics: Unilife Corp., MedPro, Prefilled Syringe

Israeli Government Awards T3 Motion 2-Year Electric Vehicle Contract

Posted by Colleen Koski

May 9, 2012 at 10:46 AM

Yesterday, T3 Motion, Inc. (TTTM-NYSE Amex) announced that the Israeli government has awarded T3 Motion and its Israeli distributor, Yaum Ltd., a two-year contract for T3 Series Electric Stand-up Vehicles (ESV). The T3 ESV is now the default personal mobility vehicle for all Israeli government agencies.

Read More

Topics: T3 Motion

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic